Life Sci
At room temperature, common airborne contaminants introduced during needle draws
Conflict of interest EP received speaker and/or consultancy fees from Angelini, Arvelle, Biogen, Biopas, Eisai, GW Pharma, PMI Life Sciences, Sanofi group of companies, SKL Life Science, Takeda, UCB Pharma, Xenon Pharma and Zogenix, and royalties from Wiley, Elsevier, and Wolters Kluwers
A randomized, double-blind phase I/IIa study of intranasal glutathione in Parkinsons disease
It's not a new fadit's an established therapeutic peptide with a growing body of research supporting its use for tissue repair, inflammation reduction, and gut health
In New South Wales, substances in Schedule 4 of the Poisons List are considered restricted substances as prescribed in the Poisons and Therapeutic Goods Act 1966 (NSW)